Advertisement
Screener

CLEARARC CAPITAL INC Historic Quarter Change: Foreign Stocks, Reduced

CLEARARC CAPITAL INC historic quarter change: Foreign Stocks, Reduced

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2016-09-30, CLEARARC CAPITAL INC opened 6 positions, added to 10, reduced 14 and sold out of 9.

  • Q4 2015: Stock NVS; Country of operation —; Class ADR; Shares before 5,624.
  • Q3 2015: Stock BP; Country of operation —; Class ADR; Shares before 19,905.
  • Q3 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 16,423.
  • Q2 2015: Stock NVS; Country of operation —; Class ADR; Shares before 12,203.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1167553), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-11); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-14); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-13); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-17); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-03-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2015NVS
NOVARTIS AG-SPONSORED ADR
ADR5,6244,172-1,452$517,000$359,000-$158,0002016-02-12
Q3 2015BP
BP PLC-SPONS ADR
ADR19,90512,928-6,977$795,000$395,000-$400,0002015-11-13
Q3 2015TEVA
TEVA PHARMACEUTICAL-SP ADR
ADR16,42312,629-3,794$971,000$713,000-$258,0002015-11-13
Q2 2015NVS
NOVARTIS AG-SPONSORED ADR
ADR12,2034,509-7,694$1,203,000$443,000-$760,0002015-08-14
Q2 2015TEVA
TEVA PHARMACEUTICAL-SP ADR
ADR16,44516,423-22$1,025,000$971,000-$54,0002015-08-14
Q2 2015SNY
SANOFI-ADR
ADR14,14614,117-29$699,000$699,000$02015-08-14
Q1 2015BP
BP PLC-SPONS ADR
ADR29,16819,220-9,948$1,112,000$752,000-$360,0002015-05-14
Q1 2015TEVA
TEVA PHARMACEUTICAL-SP ADR
ADR19,87416,445-3,429$1,143,000$1,025,000-$118,0002015-05-14
Q4 2014BP
BP PLC-SPONS ADR
ADR30,82929,168-1,661$1,355,000$1,112,000-$243,0002015-02-13
Q2 2014RHHBY
ROCHE HOLDINGS LTD-SPONS ADR
ADR51,02225,223-25,799$1,913,000$940,000-$973,0002014-08-14
Q1 2014BP
BP PLC-SPONS ADR
ADR100,60676,351-24,255$4,890,000$3,672,000-$1,218,0002014-05-15
Q1 2014TEVA
TEVA PHARMACEUTICAL-SP ADR
ADR16,35215,067-1,285$655,000$796,000+$141,0002014-05-15
Q4 2013RHHBY
ROCHE HOLDINGS LTD-SPONS ADR
ADR29,43627,666-1,770$1,985,000$1,938,000-$47,0002014-02-14
Q4 2013BP
BP PLC-SPONS ADR
ADR115,400100,606-14,794$4,850,000$4,890,000+$40,0002014-02-14

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet